The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology
Open accessAbstract
The future of radiation therapy lies in both technical and biological advances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683 · cited 1×
“PARPi compounds have generated intense interest by the oncology community since 2005, following the demonstration of synthetic lethality in BRCA-defective cells (15, 16).”
BackgroundHuman Papillomavirus and Survival of Patients with Oropharyngeal Cancer
Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912217 · Cited by 6,566
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Hellman, S., & Weichselbaum, R. R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.8 · Cited by 2,562
Self-citationOvergaard, M., Hansen, P. S., Overgaard, J., Rose, C., Andersson, M., Bach, F., Kjaer, M., Gadeberg, C. C., Mouridsen, H. T., Jensen, M.-B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371401 · Cited by 2,554
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
A restricted cell population propagates glioblastoma growth after chemotherapy
Chen, J., Li, Y., Yu, T.-S., McKay, R. M., Burns, D. K., Kernie, S. G., & Parada, L. F. (2012) · Nature · doi:10.1038/nature11287 · Cited by 2,354
KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
Lièvre, A., Bachet, J.-B., Le Corre, D., Boige, V., Landi, B., Emile, J.-F., Côté, J.-F., Tomasic, G., Penna, C., Ducreux, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0191 · Cited by 2,229
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y., Yuan, J., Kitano, S., Mu, Z., Rasalan, T., Adamow, M., Ritter, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112824 · Cited by 2,087
Bonner, J. A., Harari, P. M., Giralt, J., Cohen, R. B., Jones, C. U., Sur, R. K., Raben, D., Baselga, J., Spencer, S. A., Zhu, J., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70311-0 · Cited by 1,978
Use of Normal Tissue Complication Probability Models in the Clinic
Marks, L. B., Yorke, E. D., Jackson, A., Ten Haken, R. K., Constine, L. S., Eisbruch, A., Bentzen, S. M., Nam, J., & Deasy, J. O. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.07.1754 · Cited by 1,826
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis
Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., Fuks, Z., & Kolesnick, R. (2003) · Science · doi:10.1126/science.1082504 · Cited by 1,593
Timmerman, R., McGarry, R., Yiannoutsos, C., Papiez, L., Tudor, K., DeLuca, J., Ewing, M., Abdulrahman, R., DesRosiers, C., Williams, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.5937 · Cited by 1,556
The stereotaxic method and radiosurgery of the brain.
Leksell, L. G. (1951) · PubMed · Cited by 1,408
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Demaria, S., Ng, B., Devitt, M. L., Babb, J. S., Kawashima, N., Liebes, L., & Formenti, S. C. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.012 · Cited by 1,388
Lee, Y., Auh, S. L., Wang, Y., Burnette, B., Wang, Y., Meng, Y., Beckett, M., Sharma, R., Chin, R., Tu, T., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206870 · Cited by 1,324
Self-citationA Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Henke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,250
Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer
Kuban, D. A., Tucker, S. L., Dong, L., Starkschall, G., Huang, E. H., Cheung, M. R., Lee, A. K., & Pollack, A. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.054 · Cited by 1,232
Hickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2727 · Cited by 1,220
Ma, Y., Pannicke, U., Schwarz, K., & Lieber, M. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00671-2 · Cited by 1,166
Whole Body Irradiation—Radiobiology or Medicine?
Mole, R. H. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-305-234 · Cited by 1,123
Intensity-modulated radiation therapy, protons, and the risk of second cancers
Hall, E. J. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.027 · Cited by 1,110
Lineage Tracing Reveals Lgr5 + Stem Cell Activity in Mouse Intestinal Adenomas
Schepers, A. G., Snippert, H. J., Stange, D. E., van den Born, M., van Es, J. H., van de Wetering, M., & Clevers, H. (2012) · Science · doi:10.1126/science.1224676 · Cited by 1,072
Ragaz, J., Olivotto, I. A., Spinelli, J. J., Phillips, N., Jackson, S. M., Wilson, K. S., Knowling, M. A., Coppin, C. M. L., Weir, L., Gelmon, K., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh297 · Cited by 1,027
Gorski, D. H., Beckett, M. A., Jaskowiak, N. T., Calvin, D. P., Mauceri, H. J., Salloum, R. M., Seetharam, S., Koons, A., Hari, D. M., Kufe, D. W., et al. (1999) · PubMed · Cited by 947
Self-citationWeichselbaum, R. R., & Hellman, S. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.44 · Cited by 945
Self-citationPhase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer
Brizel, D. M., Wasserman, T. H., Henke, M., Strnad, V., Rudat, V., Monnier, A., Eschwege, F., Zhang, J., Russell, L., Oster, W., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3339 · Cited by 828
Charged particles in radiation oncology
Durante, M., & Loeffler, J. S. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.183 · Cited by 737
Levin, V. A., Bidaut, L., Hou, P., Kumar, A. J., Wefel, J. S., Bekele, B. N., Prabhu, S., Loghin, M., Gilbert, M. R., & Jackson, E. F. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.061 · Cited by 729
Rainov, N. G. (2000) · Human Gene Therapy · doi:10.1089/104303400750038499 · Cited by 698
Tumor Immunotherapy Directed at PD-1
Ribas, A. (2012) · New England Journal of Medicine · doi:10.1056/nejme1205943 · Cited by 683
Radiation-induced cell death mechanisms
Eriksson, D., & Stigbrand, T. (2010) · Tumor Biology · doi:10.1007/s13277-010-0042-8 · Cited by 666
Potters, L., Kavanagh, B., Galvin, J. M., Hevezi, J. M., Janjan, N. A., Larson, D. A., Mehta, M. P., Ryu, S., Steinberg, M., Timmerman, R., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.09.042 · Cited by 664
Particle Radiation Therapy Using Proton and Heavier Ion Beams
Schulz-Ertner, D., & Tsujii, H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7816 · Cited by 622
Weichselbaum, R. R., Ishwaran, H., Yoon, T., Nuyten, D. S. A., Baker, S. W., Khodarev, N., Su, A. W., Shaikh, A. Y., Roach, P., Kreike, B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809242105 · Cited by 615
Self-citationRadiation-Induced Bystander Effects: Past History and Future Directions
Mothersill, C., & Seymour, C. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0759:ribeph]2.0.co;2 · Cited by 507
Radiation and ceramide-induced apoptosis
Kolesnick, R., & Fuks, Z. (2003) · Oncogene · doi:10.1038/sj.onc.1206702 · Cited by 506
Bortfeld, T. (2006) · Physics in Medicine and Biology · doi:10.1088/0031-9155/51/13/r21 · Cited by 505
Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice
Langevin, F., Crossan, G. P., Rosado, I. V., Arends, M. J., & Patel, K. J. (2011) · Nature · doi:10.1038/nature10192 · Cited by 500
Donovan, E., Bleakley, N., Denholm, E., Evans, P., Gothard, L., Hanson, J., Peckitt, C., Reise, S., Ross, G., Sharp, G., et al. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.12.008 · Cited by 476
A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours
Beck, B., Driessens, G., Goossens, S., Youssef, K. K., Kuchnio, A., Caauwe, A., Sotiropoulou, P. A., Loges, S., Lapouge, G., Candi, A., et al. (2011) · Nature · doi:10.1038/nature10525 · Cited by 467
Grills, I. S., Mangona, V. S., Welsh, R., Chmielewski, G., McInerney, E., Martin, S., Wloch, J., Ye, H., & Kestin, L. L. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0928 · Cited by 464
Stress and Radiation-Induced Activation of Multiple Intracellular Signaling Pathways1
Dent, P., Yacoub, A., Contessa, J., Caron, R., Amorino, G., Valerie, K., Hagan, M. P., Grant, S., & Schmidt-Ullrich, R. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0283:sariao]2.0.co;2 · Cited by 463
Sachlos, E., Risueño, R. M., Laronde, S., Shapovalova, Z., Lee, J.-H., Russell, J., Malig, M., McNicol, J. D., Fiebig-Comyn, A., Graham, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.049 · Cited by 456
Homologous recombinational repair of DNA ensures mammalian chromosome stability
Thompson, L. H., & Schild, D. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00115-4 · Cited by 429
Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers
Overgaard, J., & Horsman, M. R. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80032-4 · Cited by 420
Stereotactic body radiation therapy: a novel treatment modality
Lo, S. S., Fakiris, A. J., Chang, E. L., Mayr, N. A., Wang, J. Z., Papiez, L., Teh, B. S., McGarry, R. C., Cardenes, H. R., & Timmerman, R. D. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.188 · Cited by 419
Recombinational DNA repair and human disease
Thompson, L. H., & Schild, D. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00224-5 · Cited by 417 · cited 1×
“Alternatively, the NHEJ pathway processes the broken DNA ends and religates them, frequently by making use of a region of microhomology (3).”
BackgroundA forward chemical genetic screen reveals an inhibitor of the Mre11–Rad50–Nbs1 complex
Dupré, A., Boyer-Chatenet, L., Sattler, R. M., Modi, A. P., Lee, J.-H., Nicolette, M. L., Kopelovich, L., Jasin, M., Baer, R., Paull, T. T., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.63 · Cited by 414
Rischin, D., Peters, L. J., O'Sullivan, B., Giralt, J., Fisher, R., Yuen, K., Trotti, A., Bernier, J., Bourhis, J., Ringash, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4449 · Cited by 380
Gulley, J. L., Arlen, P. M., Bastian, A., Morin, S., Marte, J., Beetham, P., Tsang, K.-Y., Yokokawa, J., Hodge, J. W., Ménard, C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2062 · Cited by 370
Lin, A., Kim, H. M., Terrell, J. E., Dawson, L. A., Ship, J. A., & Eisbruch, A. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00361-4 · Cited by 358
The consequences of Rad51 overexpression for normal and tumor cells
Klein, H. L. (2008) · DNA Repair · doi:10.1016/j.dnarep.2007.12.008 · Cited by 356
Down-Regulation of Rad51 and Decreased Homologous Recombination in Hypoxic Cancer Cells
Bindra, R. S., Schaffer, P. J., Meng, A., Woo, J., Måseide, K., Roth, M. E., Lizardi, P., Hedley, D. W., Bristow, R. G., & Glazer, P. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8504-8518.2004 · Cited by 356
Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma
Hoyer, M., Roed, H., Sengelov, L., Traberg, A., Ohlhuis, L., Pedersen, J., Nellemann, H., Kiil Berthelsen, A., Eberholst, F., Engelholm, S. A., et al. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.12.022 · Cited by 353
Munshi, A., Kurland, J. F., Nishikawa, T., Tanaka, T., Hobbs, M. L., Tucker, S. L., Ismail, S., Stevens, C., & Meyn, R. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2088 · Cited by 345
Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma
Hoskin, P. J., Rojas, A. M., Bentzen, S. M., & Saunders, M. I. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.4950 · Cited by 332
Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells
Rass, E., Grabarz, A., Plo, I., Gautier, J., Bertrand, P., & Lopez, B. S. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1641 · Cited by 329
Spatial and temporal control of gene therapy using ionizing radiation
Hallahan, D. E., Mauceri, H. J., Seung, L. P., Dunphy, E. J., Wayne, J. D., Hanna, N. N., Toledano, A., Hellman, S., Kufe, D. W., & Weichselbaum, R. R. (1995) · Nature Medicine · doi:10.1038/nm0895-786 · Cited by 316
Self-citationPhase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses
Seung, S. K., Curti, B. D., Crittenden, M., Walker, E., Coffey, T., Siebert, J. C., Miller, W., Payne, R., Glenn, L., Bageac, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003649 · Cited by 303
Spigel, D. R., Hainsworth, J. D., Yardley, D. A., Raefsky, E., Patton, J., Peacock, N., Farley, C., Burris, H. A., & Greco, F. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.7353 · Cited by 302
Advances in Radiotherapy and Implications for the Next Century: A Historical Perspective
Connell, P. P., & Hellman, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-07-6871 · Cited by 283
Self-citationMicroRNA Expression Characterizes Oligometastasis(es)
Lussier, Y. A., Xing, H. R., Salama, J. K., Khodarev, N. N., Huang, Y., Zhang, Q., Khan, S. A., Yang, X., Hasselle, M. D., Darga, T. E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028650 · Cited by 281
Self-citationSystems Biology Modeling of the Radiation Sensitivity Network: A Biomarker Discovery Platform
Eschrich, S., Zhang, H., Zhao, H., Boulware, D., Lee, J.-H., Bloom, G., & Torres-Roca, J. F. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.05.056 · Cited by 276
Overgaard, J., Eriksen, J. G., Nordsmark, M., Alsner, J., & Horsman, M. R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70292-8 · Cited by 274
Freytag, S. O., Stricker, H. J., Pegg, J., Paielli, D. L., Pradhan, D. G., Peabody, J. O., de Peralta‐Venturina, M., Xia, X., Brown, S., Lü, M., et al. (2003) · PubMed · Cited by 271
Harrington, K. J., Hingorani, M., Tanay, M. A., Hickey, J., Bhide, S. A., Clarke, P. M., Renouf, L. C., Thway, K., Sibtain, A., McNeish, I. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0196 · Cited by 259
Janssens, G. O., Rademakers, S. E., Terhaard, C. H., Doornaert, P. A., Bijl, H. P., van den Ende, P., Chin, A., Marres, H. A., de Bree, R., van der Kogel, A. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.9315 · Cited by 256
Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
Chan, N., Pires, I. M., Bencokova, Z., Coackley, C., Luoto, K. R., Bhogal, N., Lakshman, M., Gottipati, P., Oliver, F. J., Helleday, T., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2352 · Cited by 244
Movsas, B., Scott, C., Langer, C., Werner-Wasik, M., Nicolaou, N., Komaki, R., Machtay, M., Smith, C., Axelrod, R., Sarna, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.167 · Cited by 225
Validation of a Radiosensitivity Molecular Signature in Breast Cancer
Eschrich, S. A., Fulp, W. J., Pawitan, Y., Foekens, J. A., Smid, M., Martens, J. W. M., Echevarria, M., Kamath, V., Lee, J.-H., Harris, E. E., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0891 · Cited by 208
Phase III Study of Efaproxiral As an Adjunct to Whole-Brain Radiation Therapy for Brain Metastases
Suh, J. H., Stea, B., Nabid, A., Kresl, J. J., Fortin, A., Mercier, J.-P., Senzer, N., Chang, E. L., Boyd, A. P., Cagnoni, P. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.1768 · Cited by 195
Herman, J. M., Wild, A. T., Wang, H., Tran, P. T., Chang, K. J., Taylor, G. E., Donehower, R. C., Pawlik, T. M., Ziegler, M. A., Cai, H., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.7516 · Cited by 186
RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells
Budke, B., Logan, H. L., Kalin, J. H., Zelivianskaia, A. S., Cameron McGuire, W., Miller, L. L., Stark, J. M., Kozikowski, A. P., Bishop, D. K., & Connell, P. P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks353 · Cited by 185
Self-citationRegeneration of irradiated salivary glands with stem cell marker expressing cells
Nanduri, L. S. Y., Maimets, M., Pringle, S. A., van der Zwaag, M., van Os, R. P., & Coppes, R. P. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.085 · Cited by 180
Vascular Endothelial Growth Factor Enhances Endothelial Cell Survival and Tumor Radioresistance
Gupta, V. K., Jaskowiak, N. T., Beckett, M. A., Mauceri, H. J., Grunstein, J., Johnson, R. S., Calvin, D. A., Nodzenski, E., Pejovic, M., Kufe, D. W., et al. (2002) · The Cancer Journal · doi:10.1097/00130404-200201000-00009 · Cited by 170
Self-citationJohnson, S. M., Torrice, C. D., Bell, J. F., Monahan, K. B., Jiang, Q., Wang, Y., Ramsey, M. R., Jin, J., Wong, K.-K., Su, L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41402 · Cited by 168
Mehta, M. P., Shapiro, W. R., Phan, S. C., Gervais, R., Carrie, C., Chabot, P., Patchell, R. A., Glantz, M. J., Recht, L., Langer, C., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.05.068 · Cited by 164
Ozturk, B., Egehan, Î., Atavci, S., & Kitapci, M. T. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)01444-5 · Cited by 159
Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.
Russell, J. S., Brady, K. J., Burgan, W. E., Cerra, M. A., Oswald, K. A., Camphausen, K. A., & Tofilon, P. J. (2003) · PubMed · Cited by 157
Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice
Rotolo, J. A., Stancevic, B., Zhang, J., Hua, G., Fuller, J., Yin, X., Haimovitz‐Friedman, A., Kim, K., Qian, M. D., Cardó‐Vila, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59920 · Cited by 145
Williamson, S. K., Crowley, J. J., Lara, P. N., McCoy, J., Lau, D. H., Tucker, R. W., Mills, G. M., & Gandara, D. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.3771 · Cited by 142
Chalmers, A. J., Lakshman, M., Chan, N. H. L., & Bristow, R. G. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.06.001 · Cited by 137
Ree, A. H., Dueland, S., Folkvord, S., Hole, K. H., Seierstad, T., Johansen, M., Abrahamsen, T. W., & Flatmark, K. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70058-9 · Cited by 137
Crane, C. H., Winter, K. A., Regine, W. F., Safran, H. P., Rich, T. A., Curran, W. J., Wolff, R. A., & Willett, C. G. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8529 · Cited by 132
Rad51 siRNA delivered by HVJ envelope vector enhances the anti‐cancer effect of cisplatin
Ito, M., Yamamoto, S., Nimura, K., Hiraoka, K., Tamai, K., & Kaneda, Y. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.753 · Cited by 127
Molecular mechanisms of radiation-induced accelerated repopulation
Schmidt‐Ullrich, R., Contessa, J. N., Dent, P., Mikkelsen, R. B., Valerie, K. C., Reardon, D. B., Bowers, G. D., & Lin, P. (1999) · Radiation Oncology Investigations · doi:10.1002/(sici)1520-6823(1999)7:6<321::aid-roi2>3.0.co;2-q · Cited by 121
Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers
Powell, C. B., Mikropoulos, C., Kaye, S. B., Nutting, C. M., Bhide, S., Newbold, K. L., & Harrington, K. J. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.03.003 · Cited by 113
Small-Molecule Drugs Mimicking DNA Damage: A New Strategy for Sensitizing Tumors to Radiotherapy
Quanz, M., Berthault, N., Roulin, C., Roy, M., Herbette, A., Agrario, C., Alberti, C., Josserand, V., Coll, J., Sastre‐Garau, X., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2108 · Cited by 113
A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced death
Atkinson, J., Kapralov, A. A., Yanamala, N. V. K., Tyurina, Y. Y., Amoscato, A. A., Pearce, L. L., Peterson, J., Huang, Z., Jiang, J., Samhan-Arias, A. K., et al. (2011) · Nature Communications · doi:10.1038/ncomms1499 · Cited by 107
Zhang, F., Zhang, T., Teng, Z., Zhang, R., Wang, J., & Mei, Q. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.9.8143 · Cited by 101
Radiation-inducible Immunotherapy for Cancer: Senescent Tumor Cells as a Cancer Vaccine
Meng, Y., Efimova, E. V., Hamzeh, K., Darga, T. E., Mauceri, H. J., Fu, Y., Kron, S. J., & Weichselbaum, R. R. (2012) · Molecular Therapy · doi:10.1038/mt.2012.19 · Cited by 101
Self-citationUse of the Rad51 promoter for targeted anti-cancer therapy
Hine, C., Seluanov, A., & Gorbunova, V. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807990106 · Cited by 97
Hypofractionation for Prostate Cancer: A Critical Review
Miles, E. F., & Lee, W. R. (2008) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2007.09.006 · Cited by 92
Kamrava, M. R., Bernstein, M. B., Camphausen, K. A., & Hodge, J. W. (2009) · Molecular BioSystems · doi:10.1039/b911313b · Cited by 84
Biological Response to Radiation Therapy
Turesson, I., Carlsson, J., Brahme, A., Glimelius, B. L. G., Zackrisson, B., Stenerlöw, B., & the Swedish Cancer Society Investigation Group (2003) · Acta Oncologica · doi:10.1080/02841860310004959 · Cited by 78
Calabrese, C. R., Batey, M. A., Thomas, H. D., Durkacz, B. W., Wang, L.-Z., Kyle, S., Skalitzky, D. J., Li, J., Zhang, C. R., Boritzki, T. J., et al. (2003) · PubMed · doi:10.25405/ncl.34611858 · Cited by 78
Kennecke, H. F., Berry, S., Wong, R., Zhou, C., Tankel, K., Easaw, J. C., Rao, S. C., Post, J., & Hay, J. H. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.05.016 · Cited by 76
HORTON, J., & Wilson, S. H. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.10.016 · Cited by 74
Lind, J. S. W., Senan, S., & Smit, E. F. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4552 · Cited by 66
Mitigation of Late Renal and Pulmonary Injury After Hematopoietic Stem Cell Transplantation
Cohen, E. P., Bedi, M., Irving, A. A., Jacobs, E. R., Tomic, R., Klein, J. P., Lawton, C. A., & Moulder, J. E. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.05.081 · Cited by 62
Greenberger, J. S. (2009) · PubMed · Cited by 62
Thotala, D. K., Hallahan, D. E., & Yazlovitskaya, E. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6327 · Cited by 60
Jabbari, S., WEINBERG, V. K., Shinohara, K., Speight, J. L., GOTTSCHALK, A. R., Hsu, I.-C., Pickett, B., McLaughlin, P. W., Sandler, H. M., & Roach, M. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.01.029 · Cited by 56
Tirapazamine: laboratory data relevant to clinical activity.
Brown, J. M., & Lh, W. (1998) · PubMed · Cited by 53
Radiation sensitization with redox modulators: A promising approach
Rosenberg, A. R., & Knox, S. J. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.10.013 · Cited by 52
Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family
Finlay, M. R. V., & Griffin, R. J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.06.053 · Cited by 45
Translation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers
Weichselbaum, R. R., & Kufe, D. W. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.37 · Cited by 41
Self-citationUroporphyrinogen Decarboxylase Is a Radiosensitizing Target for Head and Neck Cancer
Ito, E., Yue, S., Moriyama, E. H., Hui, A. B., Kim, I., Shi, W., Alajez, N. M., Bhogal, N., Li, G., Datti, A., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001922 · Cited by 40
Breast cancer stem-like cells show dominant homologous recombination due to a larger S-G 2 fraction
Al‐Assar, O., Mantoni, T. S., Lunardi, S., Kingham, G. L., Helleday, T., & Brunner, T. B. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.12.15699 · Cited by 38
Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer
Ishkanian, A., Zafarana, G., Thoms, J., & Bristow, R. G. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.499371 · Cited by 33
Novel radiosensitizing anticancer therapeutics.
Linkous, A. G., & Yazlovitskaya, E. M. (2012) · PubMed · Cited by 33
Somaiah, N., Yarnold, J. R., Daley, F. M., Pearson, A., Gothard, L., Rothkamm, K., & Helleday, T. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3297 · Cited by 27
Cited by
Deng, L., Liang, H., Xu, M., Yang, X., Burnette, B., Arina, A., Li, X.-D., Mauceri, H., Beckett, M., Darga, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.019 · Cited by 2,182
“The biological responses of tumors to radiation have been demonstrated to involve DNA damage, modulation of signal transduction, and alteration of the inflammatory tumor microenvironments (Begg et al., 2011; Liauw et al., 2013).”
BackgroundSelf-citationIrradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
Deng, L., Liang, H., Burnette, B., Beckett, M., Darga, T., Weichselbaum, R. R., & Fu, Y.-X. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67313 · Cited by 2,105
Self-citationBiological response of cancer cells to radiation treatment
Baskar, R., Dai, J., Wenlong, N., Yeo, R., & Yeoh, K.-W. (2014) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2014.00024 · Cited by 638
Eccles, S. A., Aboagye, E. O., Ali, S., Anderson, A. S., Armes, J., Berditchevski, F., Blaydes, J. P., Brennan, K., Brown, N. J., Bryant, H. E., et al. (2013) · Breast Cancer Research · doi:10.1186/bcr3493 · Cited by 421
Liu, Y., Zhang, P., Li, F., Jin, X., Li, J., Chen, W., & Li, Q. (2018) · Theranostics · doi:10.7150/thno.22172 · Cited by 335
Metadata
- Authors
- Liauw, S. L., Connell, P. P., & Weichselbaum, R. R.
- Venue
- Science Translational Medicine
- Published
- 2013-02-20
- Volume
- 5
- Issue
- 173
- Pages
- 173sr2-173sr2
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2155061278
- Cited by
- 257
- References
- 119
- FWCI
- 13.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.